{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:28:20Z","timestamp":1793978900982,"version":"4.8.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijcrp.2026.200657","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:41:16Z","timestamp":1780418476000},"page":"200657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipoprotein(a) and premature myocardial infarction: Mechanistic insights and implications for PCI-era residual risk"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4486-9238","authenticated-orcid":false,"given":"Santosh mohanlal","family":"modani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravan Kumar","family":"Rampelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafi","family":"palagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiya","family":"begum Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivaramakrishnan","family":"Ramachandiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9438","key":"10.1016\/j.ijcrp.2026.200657_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200657_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/jama.297.3.286","article-title":"Risk factors for early myocardial infarction in South Asians compared with individuals in other countries","volume":"297","author":"Joshi","year":"2007","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ijcrp.2026.200657_bib3","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.114.008729","article-title":"Cardiovascular diseases in India: current epidemiology and future directions","volume":"133","author":"Prabhakaran","year":"2016","journal-title":"Circulation"},{"issue":"9765","key":"10.1016\/j.ijcrp.2026.200657_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(10)62346-X","article-title":"Stemming the global tsunami of cardiovascular disease","volume":"377","author":"Anand","year":"2011","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ijcrp.2026.200657_bib5","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200657_bib6","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.3390\/nu5072708","article-title":"Obesity and dyslipidemia in South Asians","volume":"5","author":"Misra","year":"2013","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200657_bib7","first-page":"235","article-title":"The burden of cardiovascular disease in the Indian subcontinent","volume":"124","author":"Goyal","year":"2006","journal-title":"Indian J. Med. Res."},{"issue":"22","key":"10.1016\/j.ijcrp.2026.200657_bib8","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200657_bib9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.ijcrp.2026.200657_bib10","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200657_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.ijcrp.2026.200657_bib12","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.ijcrp.2026.200657_bib13","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200657_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200657_bib15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"Par\u00e9","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200657_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"25","key":"10.1016\/j.ijcrp.2026.200657_bib17","first-page":"e1082","article-title":"2018 AHA\/ACC guideline on the management of blood cholesterol","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200657_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ihj.2019.03.004","article-title":"Lipoprotein(a): an independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction","volume":"71","author":"Enas","year":"2019","journal-title":"Indian Heart J."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200657_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ihj.2019.04.007","article-title":"Lipoprotein(a): an underrecognized genetic risk factor for malignant coronary artery disease in young Indians","volume":"71","author":"Enas","year":"2019","journal-title":"Indian Heart J."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200657_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ihj.2014.03.002","article-title":"Relook at lipoprotein(a): independent risk factor of coronary artery disease in North Indian population","volume":"66","author":"Yusuf","year":"2014","journal-title":"Indian Heart J."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200657_bib21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamacardio.2018.1470","article-title":"Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies","volume":"3","author":"Burgess","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"4932","key":"10.1016\/j.ijcrp.2026.200657_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.2530631","article-title":"The mysteries of lipoprotein(a)","volume":"246","author":"Utermann","year":"1989","journal-title":"Science"},{"issue":"6144","key":"10.1016\/j.ijcrp.2026.200657_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200657_bib24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacc.2012.04.038","article-title":"Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for novel therapy","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200657_bib25","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O'Donoghue","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200657_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ijcrp.2026.200657_bib27","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease","volume":"387","author":"O'Donoghue","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2026.200657_bib28","article-title":"Single-dose lepodisiran and sustained lowering of lipoprotein(a)","volume":"392","author":"Nissen","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200657_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcrp.2026.200657_bib30","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200657_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"10.1016\/j.ijcrp.2026.200657_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology","volume":"5","author":"Levac","year":"2010","journal-title":"Implement. Sci."},{"issue":"12A","key":"10.1016\/j.ijcrp.2026.200657_bib33","doi-asserted-by":"crossref","first-page":"57U","DOI":"10.1016\/S0002-9149(98)00954-0","article-title":"Lipoprotein(a) as a risk factor for coronary artery disease","volume":"82","author":"Marcovina","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200657_bib34","first-page":"219","article-title":"The relationship between lipoprotein(a) and the complications of atherosclerosis","volume":"173","author":"Koschinsky","year":"2004","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200657_bib35","first-page":"1325","article-title":"Lipoprotein(a): is it time for routine measurement?","volume":"65","author":"Langsted","year":"2019","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200657_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200657_bib37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1194\/jlr.R060582","article-title":"Lipoprotein(a): truly a direct prothrombotic factor in cardiovascular disease?","volume":"57","author":"Boffa","year":"2016","journal-title":"J. Lipid Res."},{"issue":"10057","key":"10.1016\/j.ijcrp.2026.200657_bib38","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in patients with elevated lipoprotein(a)","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200657_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"issue":"7414","key":"10.1016\/j.ijcrp.2026.200657_bib40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br. Med. J."},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200657_bib41","first-page":"1051","article-title":"Thrombus burden and myocardial infarction size in patients with ST-elevation MI treated with primary PCI","volume":"31","author":"Ndrepepa","year":"2010","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200657_bib42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/hc0502.102867","article-title":"No-reflow phenomenon","volume":"105","author":"Rezkalla","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200657_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200657_bib44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncpcardio0632","article-title":"No-reflow phenomenon and prognosis in patients with acute myocardial infarction","volume":"3","author":"Ito","year":"2006","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200657_bib45","first-page":"482","article-title":"Prevention and treatment of microvascular obstruction-related myocardial injury and no-reflow in primary PCI","volume":"3","author":"Jaffe","year":"2010","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcrp.2026.200657_bib46","article-title":"Microvascular obstruction and prognosis after STEMI: a CMR perspective","volume":"65","author":"Porteous","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcrp.2026.200657_bib47","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.ijcrp.2026.200657_bib48","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200657_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2019.10.057","article-title":"Lipoprotein(a) lowering with alirocumab and cardiovascular outcomes","volume":"75","author":"Bittner","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200657_bib50","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Coronary CT angiography and 5-year risk of myocardial infarction","volume":"379","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2026.200657_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2018.10.066","article-title":"Coronary artery plaque characteristics and adverse outcomes in SCOT-HEART","volume":"73","author":"Williams","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200657_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jacc.2009.02.068","article-title":"Computed tomographic angiography characteristics of atherosclerotic plaques preceding acute coronary syndrome","volume":"54","author":"Motoyama","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200657_bib53","first-page":"1","article-title":"High-risk plaque features on coronary CTA and prognosis","volume":"7","author":"Puchner","year":"2014","journal-title":"JACC, Cardiovasc. Imaging"},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200657_bib54","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jacc.2012.10.054","article-title":"Histopathologic characteristics of vulnerable plaque","volume":"61","author":"Narula","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200657_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis (PROSPECT)","volume":"364","author":"Stone","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200657_bib56","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","article-title":"Lessons from sudden coronary death","volume":"20","author":"Virmani","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200657_bib57","first-page":"3067","article-title":"Coronary risk factors and plaque morphology in men","volume":"96","author":"Burke","year":"1997","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200657_bib58","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable plaque","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200657_bib59","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.CIR.93.7.1354","article-title":"Coronary plaque erosion without rupture","volume":"93","author":"Farb","year":"1996","journal-title":"Circulation"},{"issue":"3\u20134","key":"10.1016\/j.ijcrp.2026.200657_bib60","first-page":"235","article-title":"Pathology of acute coronary syndromes","volume":"61","author":"Otsuka","year":"2014","journal-title":"J. Med. Investig."},{"issue":"6917","key":"10.1016\/j.ijcrp.2026.200657_bib61","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200657_bib62","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease (CANTOS)","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2026.200657_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.03.003","article-title":"The dedicated \u201cLp(a) clinic\u201d: a concept whose time has arrived?","volume":"300","author":"Tsimikas","year":"2020","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200657_bib64","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcrp.2026.200657_bib65","article-title":"Lipoprotein(a) and coronary heart disease risk","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200657_bib66","first-page":"272","article-title":"Update on lipoprotein(a) as a cardiovascular risk factor","volume":"24","author":"Boffa","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200657_bib67","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease: recent insights","volume":"37","author":"Kronenberg","year":"2016","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200657_bib68","first-page":"1789","article-title":"Lipoprotein(a) mass vs particle number","volume":"63","author":"Moriarty","year":"2017","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200657_bib69","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein(a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcrp.2026.200657_bib70","article-title":"Lipoprotein(a): clinical guidance and risk enhancement (scientific statements)","author":"Wilson","year":"2019","journal-title":"J. Clin. Lipidol."},{"issue":"26","key":"10.1016\/j.ijcrp.2026.200657_bib71","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction (COLCOT)","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200657_bib72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in STEMI","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"issue":"14","key":"10.1016\/j.ijcrp.2026.200657_bib73","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"ESC guidelines for NSTE-ACS","volume":"42","author":"Collet","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2026.200657_bib74","article-title":"Combination of TIMI risk score and thrombus grade in STEMI\/PCI outcomes","author":"Gibson","year":"2001","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ijcrp.2026.200657_bib75","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","article-title":"Coronary microvascular obstruction in acute MI","volume":"37","author":"Niccoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2026.200657_bib91","article-title":"Impact of hypertension on associations of all-cause mortality with admission lipoprotein(a) in acute decompensated heart failure","volume":"29","author":"Vidanage","year":"2026","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"10.1016\/j.ijcrp.2026.200657_bib92","article-title":"A study of extended lipid profile in patients with acute coronary syndrome: focus on Lipoprotein(a) and PCSK9","volume":"28","author":"Kumar","year":"2025","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"10.1016\/j.ijcrp.2026.200657_bib93","article-title":"Elevated lipoprotein(a) and adverse outcomes in advanced coronary artery calcification: an intravascular ultrasound study","volume":"29","author":"Xiao","year":"2026","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"10.1016\/j.ijcrp.2026.200657_bib94","article-title":"Lipoprotein(a) and lipid-lowering treatment from the perspective of a cardiac surgeon: an impact on the prognosis in patients with aortic valve replacement and after heart transplantation","volume":"22","author":"Surma","year":"2024","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"issue":"21","key":"10.1016\/j.ijcrp.2026.200657_bib76","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute MI (HORIZONS-AMI)","volume":"358","author":"Stone","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ijcrp.2026.200657_bib77","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","article-title":"Randomized trial of routine thrombectomy in STEMI (TOTAL)","volume":"372","author":"Jolly","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcrp.2026.200657_bib78","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","article-title":"5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction","volume":"55","author":"Ndrepepa","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200657_bib79","article-title":"Clinical utility of Lp(a) and LPA genetic risk score in risk prediction","volume":"5","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200657_bib80","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.040361","article-title":"Role of lipoprotein(a) in atherosclerotic cardiovascular disease in South Asian individuals","author":"Patel","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2026.200657_bib81","article-title":"Conventional and advanced lipid parameters in premature coronary artery disease","volume":"30","author":"Bansal","year":"2015","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.ijcrp.2026.200657_bib82","article-title":"Vascular disease in young Indians (20\u201340 years)","author":"Dalal","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.ijcrp.2026.200657_bib83","article-title":"Lipoprotein(a) and lipid profiles of patients awaiting coronary bypass: ethnic variation context","volume":"9","author":"Bandara","year":"2016","journal-title":"BMC Res. Notes"},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200657_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijcrp.2026.200657_bib86","first-page":"217","article-title":"Assessment of factors related to statin non-adherence in patients with established coronary artery disease: a single-center observational study","volume":"196","author":"Gerotziafas","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcrp.2026.200657_bib85","series-title":"Cochrane Handbook for Systematic Reviews of Interventions (Core Methods Referenced for Heterogeneity, Bias, Synthesis)","year":"2011"},{"key":"10.1016\/j.ijcrp.2026.200657_bib87","article-title":"The effect of 1-year mean step count on the change in the atherosclerotic cardiovascular disease risk calculation in patients with high cardiovascular risk: a sub-study of the LIGHT randomized clinical trial","volume":"18","author":"Doundoulakis","year":"2023","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"10.1016\/j.ijcrp.2026.200657_bib88","article-title":"Effect of a mobile application and smart devices on heart rate variability in diabetic patients with high cardiovascular risk: a sub-study of the LIGHT randomized clinical trial","volume":"18","author":"Doundoulakis","year":"2023","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"10.1016\/j.ijcrp.2026.200657_bib89","article-title":"The role of smart devices and mobile application on the change in peak VO2 in patients with high cardiovascular risk: a sub-study of the LIGHT randomised clinical trial","volume":"18","author":"Doundoulakis","year":"2023","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"10.1016\/j.ijcrp.2026.200657_bib90","article-title":"Enhanced predictive performance of the GRACE risk score by incorporating lipoprotein(a) for major adverse cardiac events in acute myocardial infarction patients undergoing PCI","volume":"22","author":"Cheng","year":"2024","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:04:56Z","timestamp":1793977496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487526000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":94,"alternative-id":["S2772487526000875"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200657","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) and premature myocardial infarction: Mechanistic insights and implications for PCI-era residual risk","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200657"}}